Cargando…
Temozolomide Drives Ferroptosis via a DMT1-Dependent Pathway in Glioblastoma Cells
PURPOSE: Temozolomide is used in first-line treatment for glioblastoma. However, chemoresistance to temozolomide is common in glioma patients. In addition, mechanisms for the anti-tumor effects of temozolomide are largely unknown. Ferroptosis is a form of programmed cell death triggered by disturbed...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Yonsei University College of Medicine
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382730/ https://www.ncbi.nlm.nih.gov/pubmed/34427071 http://dx.doi.org/10.3349/ymj.2021.62.9.843 |